---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003136"
form_type: "8-K"
ticker: "BIXT"
cik: "0001445815"
company_name: "BIOXYTRAN, INC"
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T19:01:11.686295+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bioxytran secures $1.6M stock purchase with Triton Funds; management forfeits $460K salaries

## Summary
- Triton Funds LP commits up to $1.6M for up to 17.5M shares (19.9%) at lowest traded price 10 days prior to closing.
- Proceeds: $805,000 to extinguish an existing note; balance for pre-clinical/clinical trials and working capital.
- Management forfeits more than $460,000 in accrued salaries and expenses to support the transaction.
- Closing requires effectiveness of a Form S-1 registration statement to be filed within 7 days; Triton gets $35,000 admin fee.
- The deal follows Triton's prior investment; it aims to remove convertible note overhang and fund development.

## SEC filing metadata
- accession: 0001493152-25-003136
- form_type: 8-K
- ticker: BIXT
- cik: 0001445815
- company_name: BIOXYTRAN, INC
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1445815/000149315225003136/0001493152-25-003136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1445815/000149315225003136/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003136
- JSON: https://secwatch.observer/filing/0001493152-25-003136.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003136.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.